(Q67295377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

High-performance liquid chromatographic method for determination of ciprofloxacin in biological fluids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

author name string

F Jehl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

C Gallion

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

J Debs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

J M Brogard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

H Monteil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

R Minck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

publication date

1 May 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

347-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Antibacterial activity of norfloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro activity of ciprofloxacin (Bay o 9867)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Nalidixic Acid and Hydroxynalidixic Acid Analysis in Human Plasma and Urine by Liquid Chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

High-performance liquid chromatographic analysis of roxoxacin and its N-oxide metabolite in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Determination of miloxacin and metabolites in human serum and urine by high-pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Determination of flumequine and a hydroxy metabolite in biological fluids by high-pressure liquid chromatographic, fluorometric, and microbiological methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

Pharmacokinetics and tissue penetration of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984662-9

7 January 2021

10.1016/S0378-4347(00)84662-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3159745%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference